Effect of low dose Semaglutide in people with Type 1 Diabetes and excess weight.

Diabetes research and clinical practice2024PMID: 38403174

View on PubMed DOI: 10.1016/j.diabres.2024.111593

Abstract

Obesity is a prevalent problem in people living with T1D (PwT1D), and it has been linked to cardiovascular disease in this population. The use of low dose weekly Semaglutide (0,5 mg) was evaluated in a cohort of PwT1D and excess weight.

Authors

Grassi, Bruno A; Teresa Onetto, María; Sánchez, Camila; Tapia, Nicole; Mena, Francisca

Keywords

GLP-1 receptor agonistsObesityType 1 Diabetes